MASS
908 Devices Inc
NASDAQ: MASS · HEALTHCARE · MEDICAL DEVICES
$6.83
+5.08% today
Updated 2026-04-30
Market cap
$251.94M
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$4 – $9
Volume
0.3M
908 Devices Inc (MASS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
34.70%
Operating margin
-17.30%
ROE
-25.80%
ROA
-9.02%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $22.05M | $-7.54M | 56.19% | -29.20% | -34.17% |
| 2019 | $17.97M | $-13.37M | 45.31% | -67.57% | -74.41% |
| 2020 | $26.89M | $-12.82M | 55.49% | -21.62% | -47.66% |
| 2021 | $42.21M | $-22.17M | 55.05% | -52.29% | -52.53% |
| 2022 | $46.85M | $-31.74M | 55.54% | -75.52% | -67.75% |
| 2023 | $50.23M | $-36.40M | 50.41% | -85.13% | -72.47% |
| 2024 | $59.63M | $-72.21M | 50.18% | -128.65% | -121.09% |
| 2025 | $56.20M | $19.49M | 50.58% | -70.14% | 34.68% |